Skip to main content

Advertisement

Log in

Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Post-fracture mortality in type 2 diabetes mellitus (T2DM) patients has been poorly studied. We report an absolute and relative excess all-cause mortality following a fracture in these patients compared to non-diabetic patients.

Introduction

T2DM and osteoporotic fractures are independently associated with a reduced lifespan, but it is unknown if T2DM confers an excess post-fracture mortality compared to non-diabetic fracture patients. We report post-fracture all-cause mortality according to T2DM status.

Methods

This is a population-based cohort study using data from the SIDIAP database. All ≥50 years old T2DM patients registered in SIDIAP in 2006–2013 and two diabetes-free controls matched on age, gender, and primary care center were selected. Study outcome was all-cause mortality following incident fractures. Participants were followed from date of any fracture (AF), hip fracture (HF), and clinical vertebral fracture (VF) until the earliest of death or censoring. Cox regression was used to calculate mortality according to T2DM status after adjustment for age, gender, body mass index, smoking, alcohol intake, and previous ischemic heart and cerebrovascular disease.

Results

We identified 166,106 T2DM patients and 332,212 non-diabetic, of which 11,066 and 21,564, respectively, sustained a fracture and were then included. Post-fracture mortality rates (1000 person-years) were (in T2DM vs non-diabetics) 62.7 vs 49.5 after AF, 130.7 vs 112.7 after HF, and 54.9 vs 46.2 after VF. Adjusted HR (95% CI) for post-AF, post-HF, and post-VF mortality was 1.30 (1.23–1.37), 1.28 (1.20–1.38), and 1.20 (1.06–1.35), respectively, for T2DM compared to non-diabetics.

Conclusions

T2DM patients have a 30% increased post-fracture mortality compared to non-diabetics and a remarkable excess in absolute mortality risk. More research is needed on the causes underlying such excess risk, and on the effectiveness of measures to reduce post-fracture morbi-mortality in T2DM subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311–321

    Article  PubMed  Google Scholar 

  2. Leung M-YM, Pollack LM, Colditz GA, Chang S-H (2015 Mar) Life years lost and lifetime health care expenditures associated with diabetes in the US, National Health Interview Survey, 1997–2000. Diabetes Care 38(3):460–468

    Article  PubMed  Google Scholar 

  3. Nwaneri C, Cooper H, Bowen-Jones D (2013) Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis. Br J Diabetes Vasc Dis 13(4):192–207

    Article  Google Scholar 

  4. Li W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G (2016) HbA1c and all-cause mortality risk among patients with type 2 diabetes. Int J Cardiol 202:490–496

    Article  PubMed  Google Scholar 

  5. Robinson TE, Elley CR, Kenealy T, Drury PL (2015) Development and validation of a predictive risk model for all-cause mortality in type 2 diabetes. Diabetes Res Clin Pract 108(3):482–488

    Article  PubMed  Google Scholar 

  6. Tancredi M, Rosengren A, Svensson A-M, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373(18):1720–1732

    Article  CAS  PubMed  Google Scholar 

  7. Kelly PJ, Clarke PM, Hayes AJ, Gerdtham U-G, Cederholm J, Nilsson P, Eliasson B, Gudbjornsdottir S (2014) Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data. Diabet Med 31(8):954–962

    Article  CAS  PubMed  Google Scholar 

  8. Baena-Díez JM, Peñafiel J, Subirana I, Ramos R, Elosua R, Marín-Ibañez A, Guembe MJ, Rigo F, Tormo-Díaz MJ, Moreno-Iribas C, Cabré JJ, Segura A, García-Lareo M, Gómez de la Cámara A, Lapetra J, Quesada M, Marrugat J, Medrano MJ, Berjón J, Frontera G, Gavrila D, Barricarte A, Basora J, García JM, Pavone NC, Lora-Pablos D, Mayoral E, Franch J, Mata M, Castell C, Frances A, Grau M, FRESCO Investigators (2016) Risk of cause-specific death in individuals with diabetes: a competing risks analysis. Diabetes Care dc160614

  9. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513–521

    Article  CAS  PubMed  Google Scholar 

  10. Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22(9):2439–2448

    Article  CAS  PubMed  Google Scholar 

  11. Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD (2009) Relation between fractures and mortality: results from the Canadian multicentre osteoporosis study. CMAJ 181(5):265–271

    Article  PubMed  PubMed Central  Google Scholar 

  12. Frost SA, Nguyen ND, Center JR, Eisman JA, Nguyen TV (2013) Excess mortality attributable to hip-fracture: a relative survival analysis. Bone 56(1):23–29

    Article  PubMed  Google Scholar 

  13. Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B (2010) Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39(2):203–209

    Article  PubMed  Google Scholar 

  14. Sobolev B, Sheehan KJ, Kuramoto L, Guy P (2015) Excess mortality associated with second hip fracture. Osteoporos Int 26(7):1903–1910

    Article  CAS  PubMed  Google Scholar 

  15. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475

    Article  PubMed  Google Scholar 

  16. van der Jagt-Willems HC, Vis M, Tulner CR, van Campen JPCM, Woolf AD, van Munster BC, Lems WF (2013) Mortality and incident vertebral fractures after 3 years of follow-up among geriatric patients. Osteoporos Int 24(5):1713–1719

    Article  PubMed  Google Scholar 

  17. Kado DM, Duong T, Nevitt MC, Greendale GA, Cummings SR, Stone KL, Ensrud KE (2003) Incident vertebral fractures and mortality in older women: a prospective study. Osteoporos Int 14(7):589–594

    Article  CAS  PubMed  Google Scholar 

  18. Ikeda Y, Sudo A, Yamada T, Uchida A (2010) Mortality after vertebral fractures in a Japanese population. J Orthop Surg (Hong Kong) 18(2):148–152

    Article  Google Scholar 

  19. Lee Y-K, Jang S, Jang S, Lee HJ, Park C, Ha Y-C, Kim D-Y (2012) Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int 23(7):1859–1865

    Article  PubMed  Google Scholar 

  20. Bliuc D, Nguyen TV, Eisman JA, Center JR (2014) The impact of nonhip nonvertebral fractures in elderly women and men. J Clin Endocrinol Metab 99(2):415–423

    Article  CAS  PubMed  Google Scholar 

  21. Lloret A, Coiffier G, Couchouron T, Perdriger A, Guggenbuhl P (2016) Risk factors of mortality during the first year after low energy osteoporosis fracture: a retrospective case-control study. Clin Cases Miner Bone Metab 13(2):123–126

    PubMed  PubMed Central  Google Scholar 

  22. García-Gil MDM, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, Rodriguez J, Williams T, Van Staa T, Bolíbar B (2011) Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care 19(3):135–145

    Google Scholar 

  23. Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M, Castell C, Franch-Nadal J, Bolíbar B, Mauricio D (2012) Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care 35(4):774–779

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Mata-Cases M, Franch-Nadal J, Real J, Mauricio D (2016) Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007-2013 in Catalonia: a population-based study. BMJ Open 6(10):e012463

    Article  PubMed  PubMed Central  Google Scholar 

  25. Pages-Castella A, Carbonell-Abella C, Aviles FF, Alzamora M, Baena-Diez JM, Laguna DM, Nogues X, Diez-Perez A, Prieto-Alhambra D (2012) Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study. BMC Musculoskelet Disord 13:79

    Article  PubMed  PubMed Central  Google Scholar 

  26. Premaor MO, Compston JE, Fina Avilés F, Pagès-Castellà A, Nogués X, Díez-Pérez A, Prieto-Alhambra D (2013) The association between fracture site and obesity in men: a population-based cohort study. J Bone Miner Res 28(8):1771–1777

    Article  PubMed  Google Scholar 

  27. Prieto-Alhambra D, Premaor MO, Avilés FF, Castro AS, Javaid MK, Nogués X, Arden NK, Cooper C, Compston JE, Diez-Perez A (2014) Relationship between mortality and BMI after fracture: a population-based study of men and women aged ≥40 years. J Bone Miner Res 29(8):1737–1744

    Article  PubMed  Google Scholar 

  28. Prieto-Alhambra D, Premaor MO, Fina Avilés F, Hermosilla E, Martinez-Laguna D, Carbonell-Abella C, Nogués X, Compston JE, Díez-Pérez A (2012) The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res 27(2):294–300

    Article  PubMed  Google Scholar 

  29. Reyes C, García-Gil M, Elorza JM, Fina-Avilés F, Mendez-Boo L, Hermosilla E, Coma E, Carbonell C, Medina-Peralta M, Ramos R, Bolibar B, Díez-Pérez A, Prieto-Alhambra D (2015) Socioeconomic status and its association with the risk of developing hip fractures: a region-wide ecological study. Bone 73:127–131

    Article  PubMed  Google Scholar 

  30. Carbonell-Abella C, Pages-Castella A, Javaid MK, Nogues X, Farmer AJ, Cooper C, Diez-Perez A, Prieto-Alhambra D (2015) Early (1-year) discontinuation of different anti-osteoporosis medications compared: a population-based cohort study. Calcif Tissue Int 97:535–541

    Article  CAS  PubMed  Google Scholar 

  31. Kirkwood BR, Sterne JAC, Kirkwood BR (2003) Essential medical statistics. In Blackwell Science, pp 151–3

  32. Abrahamsen B, Rosengren B, Prieto-Alhambra D, Napoli N, Cooper C (2015) Age at first major osteoporotic fracture in Danes aged 50 and over: influence of diabetes on mean age at fracture and 1 year mortality. Endocr Abstr 12

  33. Leslie WD, Brennan SL, Prior HJ, Lix LM, Metge C, Elias B (2013) The contributions of first nations ethnicity, income, and delays in surgery on mortality post-fracture: a population-based analysis. Osteoporos Int 24(4):1247–1256

    Article  CAS  PubMed  Google Scholar 

  34. Nikkel LE, Kates SL, Schreck M, Maceroli M, Mahmood B, Elfar JC (2015) Length of hospital stay after hip fracture and risk of early mortality after discharge in New York state: retrospective cohort study. BMJ 351(December):h6246

    Article  PubMed  PubMed Central  Google Scholar 

  35. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22(2):233–240

    Article  CAS  PubMed  Google Scholar 

  36. DECODE Study Group the EDEG (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161(3):397–405

    Article  Google Scholar 

  37. Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS (2008) Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 51(3):264–270

    Article  CAS  PubMed  Google Scholar 

  38. Silva HC, Pinheiro MM, Genaro PS, Castro CHM, Monteiro CMC, Fonseca FAH, Szejnfeld VL (2013) Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. Bone 52(2):562–567

    Article  PubMed  Google Scholar 

  39. Lee SN, Cho J-Y, Eun Y-M, Song S-W, Moon K-W (2016) Associations between osteoporosis and coronary artery disease in postmenopausal women. Climacteric 19(5):458–462

    Article  CAS  PubMed  Google Scholar 

  40. Vestergaard P, Rejnmark L, Mosekilde L (2007) Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 18(12):1583–1593

    Article  CAS  PubMed  Google Scholar 

  41. Melton LJ, Achenbach SJ, Atkinson EJ, Therneau TM, Amin S (2013) Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos Int 24(5):1689–1696

    Article  PubMed  Google Scholar 

  42. Huntjens KMB, Kosar S, van Geel TACM, Geusens PP, Willems P, Kessels A, Winkens B, Brink P, van Helden S (2010) Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int 21(12):2075–2082

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Brozek W, Reichardt B, Kimberger O, Zwerina J, Dimai HP, Kritsch D, Klaushofer K, Zwettler E (2014) Mortality after hip fracture in Austria 2008-2011. Calcif Tissue Int 95(3):257–266

    Article  CAS  PubMed  Google Scholar 

  44. Haentjens P, Magaziner J, Colón-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380–390

    Article  PubMed  PubMed Central  Google Scholar 

  45. Martinez-Laguna D, Soria-Castro A, Carbonell-Abella C, Orozco P, Estrada-Laza P, Nogues X, Diez-Perez A, Prieto-Alhambra D (2016) P172 validation of fragility fractures in primary care electronic medical records: a population-based study. Osteoporos Int 27(S1):79–548

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Prieto-Alhambra.

Ethics declarations

Conflicts of interest

DPA has received unrelated research grants from AMGEN, Laboratoires Servier, and UCB Pharmaceuticals. ADP has received unrelated support as speaker or advisor from Amgen, Lilly, UCB, Radius, Mereo and Active Life, and institutional research support from Amgen. BA reports institutional research contracts with Novartis and UCB Pharmaceuticals for epidemiological and pharmacovigilance studies.

Electronic supplementary material

Appendix 1

(DOCX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martinez-Laguna, D., Nogues, X., Abrahamsen, B. et al. Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study. Osteoporos Int 28, 2573–2581 (2017). https://doi.org/10.1007/s00198-017-4096-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-017-4096-y

Keywords

Navigation